^
Association details:
Biomarker:No biomarker
Cancer:Non-Hodgkin’s Lymphoma
Drug:bendamustine (DNA replication inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A1 - Approval
New
Source:
Excerpt:
TREANDA for Injection is an alkylating drug indicated for treatment of patients with...Indolent B-cell non-Hodgkin’s lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab containing regimen.